Number of the records: 1
apolipoprotein C-II
SYS d053304 LBL 02104nz--a2200349n--4500 003 CZ-PrNML 005 20240206162307.5 008 060705-n-ancnnbaba----------||-ana-----d 035 $a (DNLM)D053304 040 $a ABA008 $b cze $f czmesh 072 $a D10. $x 532. $x 091. $x 400. $x 750 072 $a D12. $x 776. $x 070. $x 400. $x 400. $x 750 072 $a D12. $x 776. $x 521. $x 120. $x 400. $x 750 150 $a apolipoprotein C-II $2 czmesh 450 $w i $a apo C-II $i UF 450 $w i $a Apo C-II $i UF 450 $w i $a apoC2 $i UF 450 $w i $a ApoC2 $i UF 450 $w i $a apolipoprotein C-2 $i UF 450 $w i $a Apolipoprotein C-2 $i UF 450 $w i $a apolipoprotein CII $i UF 450 $w i $a Apolipoprotein CII $i UF 450 $w i $a apoprotein C-II $i UF 450 $w i $a Apoprotein C-II $i UF 550 $w g $a apolipoproteiny C $7 upol_us_auth*d001056 550 $w i $a hyperlipoproteinemie typ I $i RT $7 upol_us_auth*d008072 680 $i A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS. It contains a cofactor for LIPOPROTEIN LIPASE and activates several triacylglycerol lipases. The association of Apo C-II with plasma CHYLOMICRONS; VLDL, and HIGH-DENSITY LIPOPROTEINS is reversible and changes rapidly as a function of triglyceride metabolism. Clinically, Apo C-II deficiency is similar to lipoprotein lipase deficiency (HYPERLIPOPROTEINEMIA TYPE I) and is therefore called hyperlipoproteinemia type IB. 688 $a 2007; use APOLIPOPROTEIN C-II (NM) 1978-2006 750 -2
$a Apolipoprotein C-II $2 czmesh 980 $x M 982 $a 1
Number of the records: 1